In vitro susceptibilities of Mycoplasma hominis to six fluoroquinolones as determined by E test
- PMID: 10508049
- PMCID: PMC89525
- DOI: 10.1128/AAC.43.10.2571
In vitro susceptibilities of Mycoplasma hominis to six fluoroquinolones as determined by E test
Abstract
Twenty isolates of Mycoplasma hominis were tested for their susceptibility to six fluoroquinolones by the E test. The MICs at which 90% of the isolates were inhibited (in micrograms per milliliter) were as follows: sparfloxacin, 0.031; clinafloxacin, moxifloxacin, and trovafloxacin, 0.063; levofloxacin, 0.25; and ciprofloxacin, 0.5. Increasing the amount of inoculum or incubation in CO(2) elevated MICs by </=1 dilution. E tests produce fluoroquinolone MICs comparable to those obtained by agar and microbroth dilution for M. hominis.
References
-
- Cohen M A, Huband M D. In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum to clinafloxacin, PD 131628, ciprofloxacin and comparator drugs. J Antimicrob Chemother. 1997;40:308–309. - PubMed
-
- Jones R N. Highlights from two international symposia on the subject of the expanded role of the Etest. Diagn Microbiol Infect Dis. 1994;19:149. . (Foreword.)